Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Atherosclerosis|November 9, 2011
Local delivery of IL-2 reduces atherosclerosis via expansion of regulatory T cellsThore Dietrich, Thomas Hucko, Christiane Schneemann, et al.
The International Journal of Cardiovascular Imaging|August 8, 2009
High resolution magnetic resonance imaging in atherosclerotic mice treated with ezetimibeThore Dietrich, Thomas Hucko, Riad Bourayou, et al.
Journal of Crohn'S & Colitis|December 28, 2018
Administration of the Hyper-immune Bovine Colostrum Extract IMM-124E Ameliorates Experimental Murine ColitisMarianne R Spalinger, Kirstin Atrott, Katharina Baebler, et al.
Journal of Crohn'S & Colitis|February 16, 2017
Prdx6 Deficiency Ameliorates DSS Colitis: Relevance of Compensatory Antioxidant MechanismsHassan Melhem, Marianne R Spalinger, Jesus Cosin-Roger, et al.
Basic Research in Cardiology|May 1, 2007
ED-B fibronectin (ED-B) can be targeted using a novel single chain antibody conjugate and is associated with macrophage accumulation in atherosclerotic lesionsThore Dietrich, Christin Perlitz, Kai Licha, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 14, 2022
Glycoprotein (GP)96 Is Essential for Maintaining Intestinal Epithelial Architecture by Supporting Its Self-Renewal CapacityJanine Häfliger, Marlene Schwarzfischer, Kirstin Atrott, et al.
Digestion|April 27, 2016
Deficiency of Protein Tyrosine Phosphatase Non-Receptor Type 2 in Intestinal Epithelial Cells Has No Appreciable Impact on Dextran Sulphate Sodium Colitis Severity But Promotes Wound HealingStephanie H Kasper, Marianne R Spalinger, Irina Leonardi, et al.
Journal of Crohn'S & Colitis|March 30, 2023
Spermidine Ameliorates Colitis via Induction of Anti-Inflammatory Macrophages and Prevention of Intestinal DysbiosisAnna Niechcial, Marlene Schwarzfischer, Marcin Wawrzyniak, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 17, 2026
Small Diameter Vascular Grafts Made in MinutesMichael M Peters, Kirstin Atrott, Dennis Zorndt, et al.
Inflammatory Bowel Diseases|April 13, 2021
Combination of Vedolizumab With Tacrolimus Is More Efficient Than Vedolizumab Alone in the Treatment of Experimental ColitisRoberto Manzini, Marlene Schwarzfischer, Kirstin Atrott, et al.
Pageof 5